We're beginning to see an increase in clinical disease resembling RSV infection and consequent performance of rapid RSV testing with eleven samples submitted last week, no positives detected yet. As RSV is unlikely to skip a year, we're continuing our efforts toward prevention of exposure and specific prophylaxis for those infants and children at high risk for severe lower respiratory tract infection by RSV.
